Dr Gurdeep Ahluwalia, MD | |
122 Defense Hwy Ste 222, Annapolis, MD 21401 | |
(443) 716-0420 | |
(443) 716-0419 |
Full Name | Dr Gurdeep Ahluwalia |
---|---|
Gender | Male |
Speciality | Neurology |
Experience | 22 Years |
Location | 122 Defense Hwy Ste 222, Annapolis, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083818058 | NPI | - | NPPES |
CC1923 | Other | MD | R/R MEDICARE GROUP # |
014011200 | Medicaid | MD | |
P00404659 | Other | MD | R/R MEDICARE PROVIDER # |
Facility Name | Location | Facility Type |
---|---|---|
University Of Md Baltimore Washington Medical Center | Glen burnie, MD | Hospital |
Anne Arundel Medical Center | Annapolis, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Maryland Community Medical Group Inc | 3678472214 | 351 |
News Archive
A new analysis indicates that not obtaining a medication the first time it is prescribed-called initial medication non-adherence-is common among patients within the Catalan health system in Spain.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Exact Sciences Corp. today announced it has been awarded a $244,500 therapeutic discovery grant from the Internal Revenue Service to aid the company in its development of CologuardTM, an sDNA screening test aimed at detecting both colorectal cancers and pre-cancers.
The Centers for Disease Control and Prevention (CDC) has developed a new HIV test, called the Limiting Antigen Avidity Enzyme Immunoassay, that can tell whether a person contracted the virus within the last 141 days, "hugely important information for researchers, who need to know whether fewer people are becoming newly infected with HIV to determine whether a prevention program is working," the Wall Street Journal's "Health Blog" reports.
› Verified 4 days ago
Entity Name | University Of Maryland Community Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1477530624 PECOS PAC ID: 3678472214 Enrollment ID: O20040102000687 |
News Archive
A new analysis indicates that not obtaining a medication the first time it is prescribed-called initial medication non-adherence-is common among patients within the Catalan health system in Spain.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Exact Sciences Corp. today announced it has been awarded a $244,500 therapeutic discovery grant from the Internal Revenue Service to aid the company in its development of CologuardTM, an sDNA screening test aimed at detecting both colorectal cancers and pre-cancers.
The Centers for Disease Control and Prevention (CDC) has developed a new HIV test, called the Limiting Antigen Avidity Enzyme Immunoassay, that can tell whether a person contracted the virus within the last 141 days, "hugely important information for researchers, who need to know whether fewer people are becoming newly infected with HIV to determine whether a prevention program is working," the Wall Street Journal's "Health Blog" reports.
› Verified 4 days ago
Entity Name | Metropolitan Neurological Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841703220 PECOS PAC ID: 8527328343 Enrollment ID: O20180215001766 |
News Archive
A new analysis indicates that not obtaining a medication the first time it is prescribed-called initial medication non-adherence-is common among patients within the Catalan health system in Spain.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Exact Sciences Corp. today announced it has been awarded a $244,500 therapeutic discovery grant from the Internal Revenue Service to aid the company in its development of CologuardTM, an sDNA screening test aimed at detecting both colorectal cancers and pre-cancers.
The Centers for Disease Control and Prevention (CDC) has developed a new HIV test, called the Limiting Antigen Avidity Enzyme Immunoassay, that can tell whether a person contracted the virus within the last 141 days, "hugely important information for researchers, who need to know whether fewer people are becoming newly infected with HIV to determine whether a prevention program is working," the Wall Street Journal's "Health Blog" reports.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gurdeep Ahluwalia, MD 122 Defense Hwy Ste 222, Annapolis, MD 21401-7071 Ph: (443) 716-0420 | Dr Gurdeep Ahluwalia, MD 122 Defense Hwy Ste 222, Annapolis, MD 21401 Ph: (443) 716-0420 |
News Archive
A new analysis indicates that not obtaining a medication the first time it is prescribed-called initial medication non-adherence-is common among patients within the Catalan health system in Spain.
Uniqsis has introduced FlowLab Column – an optimized flow chemistry system for heterogeneous catalysis applications.
Exact Sciences Corp. today announced it has been awarded a $244,500 therapeutic discovery grant from the Internal Revenue Service to aid the company in its development of CologuardTM, an sDNA screening test aimed at detecting both colorectal cancers and pre-cancers.
The Centers for Disease Control and Prevention (CDC) has developed a new HIV test, called the Limiting Antigen Avidity Enzyme Immunoassay, that can tell whether a person contracted the virus within the last 141 days, "hugely important information for researchers, who need to know whether fewer people are becoming newly infected with HIV to determine whether a prevention program is working," the Wall Street Journal's "Health Blog" reports.
› Verified 4 days ago
John Harold Lossing, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 2002 Medical Pkwy, Suite 430, Annapolis, MD 21401 Phone: 410-266-2740 Fax: 410-266-2758 | |
Melanie Lynn Ogunmefun, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 134 Holiday Ct, Suite 302, Annapolis, MD 21401 Phone: 410-266-1600 | |
Lewis Dean Hoover, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 49 Old Solomons Island Rd, Ste 303, Annapolis, MD 21401 Phone: 410-573-1944 Fax: 410-573-1972 | |
Dr. Richard Kron Templeton, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1203 West St Ste C, Annapolis, MD 21401 Phone: 410-263-4366 Fax: 410-268-5597 | |
Nancy Catherine Wheeler, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 133 Defense Hwy, Suite 114, Annapolis, MD 21401 Phone: 410-266-9181 Fax: 410-266-9182 | |
Melissa Anne Wellner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 166 Defense Hwy Ste 203, Annapolis, MD 21401 Phone: 410-684-3806 |